Voyager Therapeutics (VYGR) Cash from Operations (QoQ) (2015 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Cash from Operations (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.67% |
| Mar 31, 2026 | -10.43% |
| Dec 31, 2025 | 2.53% |
| Sep 30, 2025 | 6.65% |
| Jun 30, 2025 | 12.23% |
| Mar 31, 2025 | -160.82% |
| Dec 31, 2024 | 48.05% |
| Sep 30, 2024 | 11.44% |
| Jun 30, 2024 | -153.74% |
| Mar 31, 2024 | 347.34% |
| Dec 31, 2023 | -12.87% |
| Sep 30, 2023 | -2,421.08% |
| Jun 30, 2023 | -100.68% |
| Mar 31, 2023 | 1,109.19% |
| Dec 31, 2022 | 24.45% |
| Sep 30, 2022 | 12.33% |
| Jun 30, 2022 | -153.69% |
| Mar 31, 2022 | 207.51% |
| Dec 31, 2021 | 154.06% |
| Sep 30, 2021 | 8.84% |